Concepts (192)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Coumestrol | 2 | 2010 | 5 | 0.610 |
Why?
|
DDT | 2 | 2010 | 15 | 0.600 |
Why?
|
Oxides | 2 | 2014 | 89 | 0.530 |
Why?
|
Diethylhexyl Phthalate | 1 | 2014 | 4 | 0.490 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2014 | 37 | 0.480 |
Why?
|
Apoptosis | 9 | 2014 | 1398 | 0.470 |
Why?
|
Calcium-Binding Proteins | 1 | 2014 | 76 | 0.470 |
Why?
|
Glioblastoma | 1 | 2014 | 55 | 0.450 |
Why?
|
Environmental Pollutants | 2 | 2014 | 179 | 0.450 |
Why?
|
Brain Neoplasms | 1 | 2014 | 111 | 0.440 |
Why?
|
Neoplasm Proteins | 1 | 2014 | 213 | 0.420 |
Why?
|
Estrogens | 3 | 2010 | 202 | 0.340 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 2 | 2008 | 10 | 0.340 |
Why?
|
Caspases | 3 | 2008 | 147 | 0.340 |
Why?
|
Phospholipid Transfer Proteins | 1 | 2008 | 6 | 0.320 |
Why?
|
Mitochondria | 2 | 2008 | 487 | 0.290 |
Why?
|
Gene Expression Regulation | 3 | 2017 | 1015 | 0.290 |
Why?
|
Interleukin-2 | 2 | 2004 | 89 | 0.280 |
Why?
|
Phenols | 1 | 2004 | 80 | 0.220 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 6 | 2010 | 152 | 0.220 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2004 | 259 | 0.220 |
Why?
|
Cell Cycle | 5 | 2010 | 326 | 0.200 |
Why?
|
Jurkat Cells | 6 | 2008 | 79 | 0.200 |
Why?
|
Arsenicals | 2 | 2014 | 85 | 0.190 |
Why?
|
Estradiol | 4 | 2005 | 262 | 0.190 |
Why?
|
Cell Line | 7 | 2017 | 1354 | 0.170 |
Why?
|
Peroxiredoxins | 1 | 2017 | 9 | 0.150 |
Why?
|
Cardiolipins | 2 | 2008 | 11 | 0.150 |
Why?
|
Cell Proliferation | 2 | 2014 | 1198 | 0.140 |
Why?
|
Serine Endopeptidases | 1 | 2016 | 38 | 0.140 |
Why?
|
Humans | 19 | 2017 | 37093 | 0.140 |
Why?
|
RNA Interference | 1 | 2017 | 243 | 0.140 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2016 | 34 | 0.130 |
Why?
|
Oxidation-Reduction | 1 | 2017 | 431 | 0.130 |
Why?
|
Pancreatic Neoplasms | 1 | 2016 | 111 | 0.120 |
Why?
|
Lentivirus | 1 | 2014 | 21 | 0.120 |
Why?
|
Cell Movement | 2 | 2017 | 571 | 0.120 |
Why?
|
Proto-Oncogene Proteins | 1 | 2016 | 239 | 0.120 |
Why?
|
Blotting, Western | 5 | 2010 | 859 | 0.120 |
Why?
|
Adenocarcinoma | 1 | 2016 | 251 | 0.120 |
Why?
|
DNA Damage | 2 | 2014 | 352 | 0.110 |
Why?
|
Membrane Proteins | 2 | 2016 | 517 | 0.110 |
Why?
|
Gene Knockdown Techniques | 1 | 2014 | 173 | 0.110 |
Why?
|
Gene Silencing | 1 | 2014 | 151 | 0.110 |
Why?
|
Caspase 3 | 3 | 2010 | 207 | 0.110 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2014 | 172 | 0.110 |
Why?
|
Cell Survival | 2 | 2014 | 864 | 0.110 |
Why?
|
T-Lymphocytes | 3 | 2005 | 357 | 0.100 |
Why?
|
MicroRNAs | 1 | 2017 | 426 | 0.100 |
Why?
|
Heme Oxygenase (Decyclizing) | 2 | 2001 | 30 | 0.100 |
Why?
|
Hela Cells | 2 | 2010 | 366 | 0.100 |
Why?
|
Protein Kinase C-delta | 2 | 2008 | 18 | 0.100 |
Why?
|
Models, Biological | 2 | 2017 | 677 | 0.090 |
Why?
|
Cell Line, Tumor | 2 | 2014 | 2231 | 0.090 |
Why?
|
Enzyme Activation | 2 | 2008 | 444 | 0.090 |
Why?
|
Protein Binding | 3 | 2017 | 972 | 0.090 |
Why?
|
DNA Replication | 1 | 2010 | 152 | 0.080 |
Why?
|
Transfection | 2 | 2008 | 523 | 0.080 |
Why?
|
Recombinant Proteins | 2 | 2008 | 515 | 0.080 |
Why?
|
Caspase 8 | 1 | 2008 | 32 | 0.080 |
Why?
|
Membrane Lipids | 1 | 2008 | 33 | 0.080 |
Why?
|
Progesterone | 3 | 2003 | 113 | 0.080 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2008 | 188 | 0.080 |
Why?
|
DNA Primers | 1 | 2008 | 286 | 0.080 |
Why?
|
Endocytosis | 1 | 2008 | 113 | 0.080 |
Why?
|
Testosterone | 2 | 2005 | 193 | 0.070 |
Why?
|
RNA, Messenger | 4 | 2004 | 1207 | 0.070 |
Why?
|
Base Sequence | 1 | 2008 | 997 | 0.070 |
Why?
|
RNA, Small Interfering | 1 | 2008 | 409 | 0.070 |
Why?
|
Lung Neoplasms | 1 | 2010 | 358 | 0.070 |
Why?
|
Lymphocyte Activation | 2 | 2004 | 236 | 0.070 |
Why?
|
Endostatins | 1 | 2005 | 5 | 0.070 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2005 | 356 | 0.070 |
Why?
|
Lipopolysaccharides | 3 | 2003 | 220 | 0.060 |
Why?
|
Ultraviolet Rays | 1 | 2005 | 117 | 0.060 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2005 | 147 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2016 | 807 | 0.060 |
Why?
|
Estrogens, Non-Steroidal | 1 | 2004 | 19 | 0.060 |
Why?
|
Membrane Glycoproteins | 1 | 2005 | 211 | 0.060 |
Why?
|
NF-kappa B | 2 | 2004 | 339 | 0.060 |
Why?
|
Insecticides | 1 | 2004 | 51 | 0.060 |
Why?
|
Benzhydryl Compounds | 1 | 2004 | 43 | 0.060 |
Why?
|
Electromagnetic Fields | 1 | 2003 | 8 | 0.060 |
Why?
|
Osteosarcoma | 1 | 2003 | 26 | 0.050 |
Why?
|
Bone Neoplasms | 1 | 2003 | 45 | 0.050 |
Why?
|
Hemin | 1 | 2001 | 6 | 0.050 |
Why?
|
Tissue Preservation | 1 | 2001 | 7 | 0.050 |
Why?
|
Cyclin A | 1 | 2001 | 5 | 0.050 |
Why?
|
Kidney Tubules, Proximal | 1 | 2001 | 28 | 0.050 |
Why?
|
Receptors, Interleukin-2 | 1 | 2001 | 32 | 0.050 |
Why?
|
Sialoglycoproteins | 1 | 2001 | 11 | 0.050 |
Why?
|
Cyclosporine | 1 | 2001 | 27 | 0.050 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2001 | 41 | 0.050 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2001 | 168 | 0.050 |
Why?
|
Monocytes | 1 | 2003 | 257 | 0.050 |
Why?
|
Kidney Tubules | 1 | 2001 | 33 | 0.050 |
Why?
|
Gonadal Steroid Hormones | 1 | 2001 | 51 | 0.050 |
Why?
|
Vitamin E | 1 | 2001 | 61 | 0.050 |
Why?
|
B-Lymphocytes | 1 | 2001 | 185 | 0.040 |
Why?
|
Inflammation Mediators | 1 | 2001 | 123 | 0.040 |
Why?
|
Transcription, Genetic | 2 | 2001 | 578 | 0.040 |
Why?
|
Signal Transduction | 2 | 2005 | 1908 | 0.040 |
Why?
|
Transforming Growth Factor beta | 1 | 2001 | 197 | 0.040 |
Why?
|
Kidney Diseases | 1 | 2001 | 167 | 0.040 |
Why?
|
Cytokines | 2 | 2001 | 602 | 0.040 |
Why?
|
Kidney | 1 | 2001 | 337 | 0.040 |
Why?
|
Antioxidants | 1 | 2001 | 416 | 0.040 |
Why?
|
Thymidine | 2 | 2010 | 15 | 0.040 |
Why?
|
Macrophages | 1 | 2001 | 439 | 0.040 |
Why?
|
Disulfides | 1 | 2017 | 77 | 0.040 |
Why?
|
Carcinoma in Situ | 1 | 2016 | 12 | 0.030 |
Why?
|
Protein Transport | 1 | 2017 | 302 | 0.030 |
Why?
|
Binding Sites | 1 | 2017 | 651 | 0.030 |
Why?
|
Promoter Regions, Genetic | 1 | 2017 | 515 | 0.030 |
Why?
|
Disease Progression | 1 | 2016 | 601 | 0.030 |
Why?
|
Prognosis | 1 | 2016 | 739 | 0.030 |
Why?
|
Follow-Up Studies | 1 | 2016 | 974 | 0.030 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2005 | 213 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2016 | 1130 | 0.030 |
Why?
|
Female | 2 | 2010 | 20969 | 0.030 |
Why?
|
Early Detection of Cancer | 1 | 2016 | 336 | 0.030 |
Why?
|
DNA Fragmentation | 2 | 2003 | 92 | 0.030 |
Why?
|
Tumor Cells, Cultured | 2 | 2003 | 502 | 0.030 |
Why?
|
Oxidative Stress | 1 | 2017 | 938 | 0.020 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2010 | 95 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2001 | 623 | 0.020 |
Why?
|
Monensin | 1 | 2008 | 4 | 0.020 |
Why?
|
Fas Ligand Protein | 1 | 2008 | 16 | 0.020 |
Why?
|
Staurosporine | 1 | 2008 | 38 | 0.020 |
Why?
|
Matrix Metalloproteinases | 1 | 2008 | 48 | 0.020 |
Why?
|
Immunoblotting | 1 | 2008 | 176 | 0.020 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2008 | 84 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2008 | 189 | 0.020 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2008 | 146 | 0.020 |
Why?
|
Gene Expression | 2 | 2001 | 674 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2001 | 1518 | 0.020 |
Why?
|
Time Factors | 2 | 2001 | 1742 | 0.020 |
Why?
|
Diglycerides | 1 | 2005 | 10 | 0.020 |
Why?
|
Phospholipases | 1 | 2005 | 8 | 0.020 |
Why?
|
Intracellular Membranes | 1 | 2005 | 38 | 0.020 |
Why?
|
Comet Assay | 1 | 2005 | 76 | 0.020 |
Why?
|
Membrane Potentials | 1 | 2005 | 223 | 0.020 |
Why?
|
Magnesium | 1 | 2005 | 97 | 0.020 |
Why?
|
Receptors, Estradiol | 1 | 2003 | 2 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2005 | 237 | 0.010 |
Why?
|
U937 Cells | 1 | 2003 | 27 | 0.010 |
Why?
|
K562 Cells | 1 | 2003 | 32 | 0.010 |
Why?
|
HL-60 Cells | 1 | 2003 | 32 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 2003 | 108 | 0.010 |
Why?
|
Down-Regulation | 1 | 2005 | 435 | 0.010 |
Why?
|
Osteoblasts | 1 | 2003 | 35 | 0.010 |
Why?
|
Proline | 1 | 2003 | 43 | 0.010 |
Why?
|
Receptors, Progesterone | 1 | 2003 | 81 | 0.010 |
Why?
|
Reference Values | 1 | 2003 | 212 | 0.010 |
Why?
|
Calcium | 1 | 2005 | 480 | 0.010 |
Why?
|
Cell Division | 1 | 2003 | 307 | 0.010 |
Why?
|
Deferoxamine | 1 | 2001 | 19 | 0.010 |
Why?
|
Enzyme Induction | 1 | 2001 | 53 | 0.010 |
Why?
|
RNA Probes | 1 | 2001 | 10 | 0.010 |
Why?
|
Heme Oxygenase-1 | 1 | 2001 | 51 | 0.010 |
Why?
|
Cold Temperature | 1 | 2001 | 40 | 0.010 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2001 | 62 | 0.010 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2001 | 59 | 0.010 |
Why?
|
Ferritins | 1 | 2001 | 55 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2003 | 562 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 2001 | 133 | 0.010 |
Why?
|
Cell Size | 1 | 2001 | 44 | 0.010 |
Why?
|
Culture Media | 1 | 2001 | 90 | 0.010 |
Why?
|
Osteopontin | 1 | 2001 | 36 | 0.010 |
Why?
|
Lymphocytes | 1 | 2001 | 118 | 0.010 |
Why?
|
Drug Resistance | 1 | 2001 | 99 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 2001 | 142 | 0.010 |
Why?
|
Kinetics | 1 | 2001 | 708 | 0.010 |
Why?
|
Cell Adhesion | 1 | 2001 | 212 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2001 | 399 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2001 | 448 | 0.010 |
Why?
|
Cell Nucleus | 1 | 2001 | 366 | 0.010 |
Why?
|
Dactinomycin | 1 | 1998 | 11 | 0.010 |
Why?
|
Receptors, Interleukin-1 | 1 | 1998 | 8 | 0.010 |
Why?
|
Cycloheximide | 1 | 1998 | 30 | 0.010 |
Why?
|
Interleukin-1 | 1 | 1998 | 35 | 0.010 |
Why?
|
Nitric Oxide | 1 | 2001 | 316 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2001 | 1039 | 0.010 |
Why?
|
Proteins | 1 | 2001 | 369 | 0.010 |
Why?
|
Sex Factors | 1 | 2001 | 898 | 0.010 |
Why?
|
Pregnancy | 1 | 2003 | 1549 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2001 | 1618 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2001 | 1371 | 0.010 |
Why?
|
Animals | 2 | 2001 | 15081 | 0.010 |
Why?
|
Rats | 1 | 2001 | 3483 | 0.010 |
Why?
|
Male | 2 | 2001 | 20025 | 0.010 |
Why?
|
Mice | 1 | 2001 | 5913 | 0.010 |
Why?
|